Lemaitre Vascular (LMAT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $83.16, +0.65% vs the prior close of $82.62.
- Volume 297.90K shares, 0.9x its 50-day average.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
LMAT rises 0.7% to $83.16, a 1-month high. Closed at $83.16, +0.65% vs the prior close of $82.62. Day range $82.87–$84.66, opened at $83.82.
LMAT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LMAT rises 0.7% to $83.16, a 1-month high
- Closed at $83.16, +0.65% vs the prior close of $82.62. Day range $82.87–$84.66, opened at $83.82.
- Volume was 297.90K shares, 0.9x its 50-day average of 340.81K.
- Price is +2.8% vs its 50-day average ($80.92) and -12.0% vs its 200-day average ($94.46).
- 52-week range $78.22–$118.01; today's close sits at 12% of that range, 29.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — LMAT rises 1.3% to $82.62
- Closed at $82.62, +1.31% vs the prior close of $81.55. Day range $80.81–$82.92, opened at $81.26.
- Volume was 316.00K shares, 0.9x its 50-day average of 342.65K.
- Price is +2.2% vs its 50-day average ($80.83) and -12.5% vs its 200-day average ($94.46).
- 52-week range $78.22–$118.01; today's close sits at 11% of that range, 30.0% below the 52-week high.
Oct 13, 2026 — LMAT dips 1.6% to $81.55
- Closed at $81.55, -1.64% vs the prior close of $82.91. Day range $81.29–$83.85, opened at $83.64.
- Volume was 247.80K shares, 0.7x its 50-day average of 344.12K.
- Price is +0.3% vs its 50-day average ($81.30) and -13.7% vs its 200-day average ($94.47).
- 52-week range $78.22–$118.01; today's close sits at 8% of that range, 30.9% below the 52-week high.
Oct 12, 2026 — LMAT rises 2.8% to $82.91, a 1-month high, 4 up days in a row
- Closed at $82.91, +2.75% vs the prior close of $80.69. Day range $80.03–$83.25, opened at $80.77.
- Volume was 257.90K shares, 0.8x its 50-day average of 343.64K.
- Price is +1.4% vs its 50-day average ($81.74) and -12.2% vs its 200-day average ($94.48).
- 52-week range $78.22–$118.01; today's close sits at 12% of that range, 29.7% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — LMAT rises 1.3% to $80.69, 3 up days in a row
- Closed at $80.69, +1.32% vs the prior close of $79.64. Day range $79.58–$81.02, opened at $79.58.
- Volume was 126.70K shares, 0.4x its 50-day average of 344.84K — lighter than usual.
- Price is -1.7% vs its 50-day average ($82.11) and -14.6% vs its 200-day average ($94.49).
- 52-week range $78.22–$118.01; today's close sits at 6% of that range, 31.6% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — LMAT rises 0.4% to $79.64
- Closed at $79.64, +0.42% vs the prior close of $79.31. Day range $78.31–$80.16, opened at $79.31.
- Volume was 272.90K shares, 0.8x its 50-day average of 345.64K.
- Price is -3.5% vs its 50-day average ($82.54) and -15.7% vs its 200-day average ($94.51).
- 52-week range $78.22–$118.01; today's close sits at 4% of that range, 32.5% below the 52-week high.
Oct 7, 2026 — LMAT rises 0.3% to $79.31
- Closed at $79.31, +0.33% vs the prior close of $79.05. Day range $78.58–$80.47, opened at $78.76.
- Volume was 218.30K shares, 0.6x its 50-day average of 347.64K.
- Price is -4.5% vs its 50-day average ($83.02) and -16.1% vs its 200-day average ($94.53).
- 52-week range $78.22–$118.01; today's close sits at 3% of that range, 32.8% below the 52-week high.
Oct 6, 2026 — LMAT dips 2.4% to $79.05
- Closed at $79.05, -2.40% vs the prior close of $80.99. Day range $78.90–$81.21, opened at $81.04.
- Volume was 283.40K shares, 0.8x its 50-day average of 347.67K.
- Price is -5.3% vs its 50-day average ($83.48) and -16.4% vs its 200-day average ($94.56).
- 52-week range $78.22–$118.01; today's close sits at 2% of that range, 33.0% below the 52-week high.
Oct 5, 2026 — LMAT rises 2.6% to $80.99
- Closed at $80.99, +2.57% vs the prior close of $78.96. Day range $78.49–$81.83, opened at $79.00.
- Volume was 369.80K shares, 1.1x its 50-day average of 347.26K.
- Price is -3.4% vs its 50-day average ($83.87) and -14.4% vs its 200-day average ($94.59).
- 52-week range $78.22–$118.01; today's close sits at 7% of that range, 31.4% below the 52-week high.
Oct 2, 2026 — LMAT dips 1.5% to $78.96, 3 down days in a row
- Closed at $78.96, -1.53% vs the prior close of $80.19. Day range $78.66–$81.36, opened at $81.36.
- Volume was 325.70K shares, 0.9x its 50-day average of 346.48K.
- Price is -6.2% vs its 50-day average ($84.17) and -16.5% vs its 200-day average ($94.60).
- 52-week range $78.22–$118.01; today's close sits at 2% of that range, 33.1% below the 52-week high.
- That makes 3 straight losses.
LMAT latest news & SEC filings
Every SEC filing by or about LMAT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $17.05M (prior year $13.78M) (+23.7% vs Jun 30, 2025)
- Diluted EPS: $0.74 (prior year $0.60) (+23.3% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LMAT
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 25, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.25% (largest 2.9%).
- Liquidity: about 268.65K shares (≈$22.34M) trade per day on average.
- 52-week position: $83.16 vs a range of $78.22–$118.01 (12% of the range).
- Dividends: last ex-dividend date Aug 20, 2026 ($0.25/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 11 sales; latest: George W Lemaitre sold 27,881 shares on May 8, 2026.
- Latest filings: 8-K Oct 15, 2026; 10-Q Aug 5, 2026; 8-K Aug 4, 2026.
- Share count: 22.87M shares outstanding (Aug 2, 2026), +1.0% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
LMAT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 83.82 | 84.66 | 82.87 | 83.16 | 297.90K |
| Oct 14, 2026 | 81.26 | 82.92 | 80.81 | 82.62 | 316.00K |
| Oct 13, 2026 | 83.64 | 83.85 | 81.29 | 81.55 | 247.80K |
| Oct 12, 2026 | 80.77 | 83.25 | 80.03 | 82.91 | 257.90K |
| Oct 9, 2026 | 79.58 | 81.02 | 79.58 | 80.69 | 126.70K |
| Oct 8, 2026 | 79.31 | 80.16 | 78.31 | 79.64 | 272.90K |
| Oct 7, 2026 | 78.76 | 80.47 | 78.58 | 79.31 | 218.30K |
| Oct 6, 2026 | 81.04 | 81.21 | 78.90 | 79.05 | 283.40K |
| Oct 5, 2026 | 79.00 | 81.83 | 78.49 | 80.99 | 369.80K |
| Oct 2, 2026 | 81.36 | 81.36 | 78.66 | 78.96 | 325.70K |
| Oct 1, 2026 | 82.80 | 83.05 | 79.97 | 80.19 | 302.20K |
| Sep 30, 2026 | 82.81 | 83.35 | 81.82 | 82.59 | 207.90K |
| Sep 29, 2026 | 82.13 | 82.99 | 81.25 | 82.89 | 227.10K |
| Sep 28, 2026 | 81.29 | 82.82 | 80.39 | 82.34 | 238.90K |
| Sep 25, 2026 | 80.69 | 81.88 | 79.97 | 81.52 | 230.30K |
| Sep 24, 2026 | 80.64 | 81.37 | 79.67 | 80.82 | 321.30K |
| Sep 23, 2026 | 80.70 | 81.52 | 79.84 | 80.58 | 247.10K |
| Sep 22, 2026 | 79.84 | 81.32 | 79.69 | 80.98 | 260.90K |
| Sep 21, 2026 | 78.87 | 79.50 | 78.22 | 79.20 | 221.50K |
| Sep 18, 2026 | 79.25 | 79.60 | 78.51 | 78.87 | 399.40K |
About Lemaitre Vascular
Lemaitre Vascular (LMAT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BURLINGTON, MA. Fiscal year ends December 31. SEC CIK 1158895.
LMAT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lawrence J Jasinski | Director | Sep 8, 2026 |
| George W Lemaitre | Chairman and CEO | Sep 8, 2026 |
| John James O'Connor | Director | Sep 8, 2026 |
| Joseph P Jr Pellegrino | Director | Sep 8, 2026 |
| David B Roberts | President and Director | Sep 8, 2026 |
| Bridget A Ross | Director | May 11, 2026 |
| John A Roush | Director | Sep 8, 2026 |
| Martha Shadan | Director | Sep 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Trent G Kamke | Senior V. P., Operations | Sep 8, 2026 |
| Dorian Paul Leblanc | Chief Financial Officer | Sep 8, 2026 |
| George W Lemaitre | Chairman and CEO | Sep 8, 2026 |
| David B Roberts | President and Director | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 8, 2026 | George W Lemaitre | Sale | 27,881 | $108.69 |
| May 8, 2026 | Trent G Kamke | Sale | 2,928 | $107.00 |
| May 7, 2026 | Bridget A Ross | Sale | 5,044 | $111.10 |
| May 7, 2026 | George W Lemaitre | Sale | 18,600 | $107.64 |
| May 7, 2026 | Lawrence J Jasinski | Sale | 3,943 | $110.00 |
| Mar 11, 2026 | Trent G Kamke | Sale | 2,625 | $108.50 |
| Mar 11, 2026 | David B Roberts | Sale | 3,312 | $107.68 |
| Mar 2, 2026 | George W Lemaitre | Sale | 55,930 | $107.81 |
| Feb 27, 2026 | Trent G Kamke | Sale | 1,044 | $110.29 |
| Feb 27, 2026 | David B Roberts | Sale | 8,464 | $106.80 |
| Feb 26, 2026 | George W Lemaitre | Sale | 150,000 | $106.76 |
LMAT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $249.60M | $57.73M | 2.52 | $81.25M |
| Dec 31, 2024 | $219.86M | $44.04M | 1.93 | $44.12M |
| Dec 31, 2023 | $193.48M | $30.11M | 1.34 | $36.75M |
| Dec 31, 2022 | $161.65M | $20.64M | 0.93 | $25.38M |
| Dec 31, 2021 | $154.42M | $26.91M | 1.25 | $35.10M |
Latest balance sheet: total assets $640.55M, total liabilities $220.21M, cash $26.62M (as of Jun 30, 2026).
LMAT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $105.78 |
| May 5, 2026 | 8-K Item 2.02 (results) | $112.00 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $91.38 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $85.60 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $85.60 |
| May 1, 2025 | 8-K Item 2.02 (results) | $90.24 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $99.91 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $88.39 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LMAT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.